| Garrett Kroon, | |
|
3061 S Meridian Rd Ste 100, Meridian, ID 83642-7962 | |
| (208) 477-8796 | |
| Not Available |
| Full Name | Garrett Kroon |
|---|---|
| Gender | Male |
| Speciality | Counselor - Mental Health |
| Location | 3061 S Meridian Rd Ste 100, Meridian, Idaho |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033688007 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101Y00000X | Counselor | (* (Not Available)) | Secondary |
| 101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Garrett Kroon, 2419 E Massachusetts Ave, Nampa, ID 83686-6295 Ph: (208) 477-8796 | Garrett Kroon, 3061 S Meridian Rd Ste 100, Meridian, ID 83642-7962 Ph: (208) 477-8796 |
News Archive
Far more breast cancer patients are choosing to undergo mastectomy, including removal of both breasts, instead of choosing breast conservation surgery even when they have early stage disease that is confined to one breast, a Vanderbilt study shows. In the past decade, there have also been marked trends toward higher proportions of women opting for breast reconstruction.
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced the initiation of Phase II clinical trial of the company's investigative immunomodulatory agent, CYT107 (rhIL-7), in combination with two potent antiretroviral drugs represented by the integrase inhibitor raltegravir (ISENTRESS- Merck & Co.) and the CCR5 inhibitor, maraviroc (SELZENTRY- ViiV Healthcare).
Researchers at Amgen are testing a fully human monoclonal antibody that inhibits the activity of insulin-like growth factors (IGF-1 and IGF-2) and appears to reduce pancreatic cancer cells in early testing, according to a report in Molecular Cancer Therapeutics, a journal of the American Association for Cancer Research.
The WHO has issued new guidelines for the treatment of three common sexually transmitted diseases (STDs) due to concerns about increasing levels of antibiotic resistance.
› Verified 3 days ago
Diane Smith, Counselor Medicare: Medicare Enrolled Practice Location: 2131 S Bonito Way, Meridian, ID 83642 Phone: 208-202-4732 | |
Gregory M Deitchler, MA L.M.F.T., L.P.C., Counselor Medicare: Not Enrolled in Medicare Practice Location: 3061 S. Meridian Rd., Suite 100, Meridian, ID 83642 Phone: 208-350-0330 Fax: 208-576-6915 | |
Mrs. Chris Zukowski, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1650 S Topaz Way, Meridian, ID 83642 Phone: 208-888-3151 | |
Tami Marie Morgan, Counselor Medicare: Not Enrolled in Medicare Practice Location: 3597 E Monarch Sky Ln Ste F-240, Meridian, ID 83646 Phone: 208-890-7165 | |
Shelby Martini, LPC, NCC Counselor Medicare: Not Enrolled in Medicare Practice Location: 750 W Ustick Rd Ste 120, Meridian, ID 83646 Phone: 208-506-0520 | |
Heather Anne Davis, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 3043 S Meridian Rd, Suite 125, Meridian, ID 83642 Phone: 208-884-0033 Fax: 208-884-5258 | |
Layne Dillingham, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 849 E Fairview Ave, Meridian, ID 83642 Phone: 661-859-9336 |